AFT Pharmaceuticals starts to hit its straps

By Pattrick Smellie | Thu, 21 Nov 2019


Maxigesic painkiller manufacturer AFT Pharmaceuticals is starting to deliver on the growth strategy funded by its 2015 NZX listing, with sales in South East Asia rocketing ahead in the first six months of this year and in line with company expectations in the six months to Sept. 30.While growth in its largest market, Australia, slowed markedly and New Zealand sales fell compared to the same period a year ago, the appearance of momentum in SE Asian and 'rest of world' sales meant the Auckland-based drug maker maintained revenue growth at 22.1 pe...